HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.

Abstract
The polycystic kidney (PCK) rat is an animal model of Caroli's disease with congenital hepatic fibrosis, in which the mechanism of progressive hepatic fibrosis remains unknown. This study aimed to clarify the mechanism of hepatic fibrosis of the PCK rat from the viewpoint of the contribution of pathological cholangiocytes. In liver sections of the PCK rats, intrahepatic bile ducts were constituted by two different phenotypes: bile ducts lined by cuboidal-shaped and flat-shaped cholangiocytes. The flat-shaped cholangiocytes showed reduced immunohistochemical expression of the biliary epithelial marker cytokeratin 19 and positive immunoreactivity for vimentin and fibronectin. When cultured cholangiocytes of the PCK rat were treated with transforming growth factor (TGF)-beta1, a potent inducer of epithelial-mesenchymal transition, induction of vimentin, fibronectin, and collagen expression occurred in the PCK cholangiocytes. Although the TGF-beta1 treatment reduced cytokeratin 19 expression, the epithelial cell features characterized by the expression of E-cadherin and zonula occludens-1 was maintained, and alpha-smooth muscle actin expression was not induced in the cholangiocytes. Cholangiocytes of the PCK rat may acquire mesenchymal features in response to TGF-beta1 and participate in progressive hepatic fibrosis by producing extracellular matrix molecules, which seems to be a different event from epithelial-mesenchymal transition.
AuthorsYasunori Sato, Kenichi Harada, Satoru Ozaki, Shinichi Furubo, Kazuo Kizawa, Takahiro Sanzen, Mitsue Yasoshima, Hiroko Ikeda, Motoko Sasaki, Yasuni Nakanuma
JournalThe American journal of pathology (Am J Pathol) Vol. 171 Issue 6 Pg. 1859-71 (Dec 2007) ISSN: 0002-9440 [Print] United States
PMID18055542 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Receptors, Transforming Growth Factor beta
  • Transforming Growth Factor beta1
Topics
  • Aging
  • Animals
  • Bile Ducts (immunology, pathology)
  • Biomarkers (metabolism)
  • Caroli Disease (complications)
  • Disease Models, Animal
  • Liver Cirrhosis (etiology, pathology)
  • Male
  • Mesoderm (pathology)
  • Polycystic Kidney Diseases (complications)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Transforming Growth Factor beta (metabolism)
  • Transforming Growth Factor beta1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: